查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750664

全球液態生物檢體市場：市場規模、佔有率、趨勢分析（按生物標記、技術、樣本類型、應用、臨床用途、最終用途、產品和地區）、細分市場預測（2025-2030 年）

Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

液態生物檢體市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，預計到2030年全球液態生物檢體市場規模將達到228.8億美元，2025年至2030年的複合年成長率為11.54%。

癌症發生率的上升和老年人口的成長是推動市場成長的主要因素。此外，使用先進的技術設備進行疾病的早期檢測也是推動市場成長的主要因素之一。此外，在預測期內，人們對非侵入性治療方法的日益偏好可能會帶來豐厚的機會。

近年來，癌症患者數量顯著增加，預計這一趨勢還將持續一段時間。生活方式的顯著改變使世界人口面臨癌症疾病和致癌因素的風險。例如，根據美國癌症協會的數據，預計到2022年，全球新增癌症病例將達到190萬，導致609,360人死亡。各大公司正致力於拓展臨床液態生物檢體領域的業務。

例如，2021年12月，Helio Health和Fulgent Genetics宣布推出HelioLiver，這是一種用於早期檢測肝癌的新型液態生物檢體檢測。此液態生物檢體檢測將血清蛋白標記物與遊離DNA甲基化模式結合。此外，新的研發活動正在推動新型液態生物檢體技術的開發。例如，2022年7月，中佛羅裡達大學宣布開發一種新型液態生物檢體技術，該技術利用肺癌和乳癌的生物標記來促進早期檢測並方便病情監測。

企業對液態生物檢體日益成長的興趣以及新產品核准的上升，進一步推動了市場的成長。此外，過去幾年的研究也顯示液態生物檢體平台取得了積極的結果。各國政府和各監管機構也對該領域表現出濃厚的興趣，並推廣了多種突破性設備，以促進該技術的快速發展。隨著各公司對該技術的廣泛採用，以及政府的資金和舉措的支持，預計未來幾年市場將會成長。

液態生物檢體市場：概述

  • 基於技術，次世代定序 (NGS) 領域預計將在 2024 年以 76.17% 的最大收益佔有率引領市場，並預計在預測期內以最快的複合年成長率成長。
  • 根據生物標記，循環性腫瘤細胞(CTC) 生物標記部分在 2024 年佔據市場最大收益佔有率，為 35.67%。預計外泌體/微泡部分在預測期內將以 13.82% 的最快複合年成長率成長。
  • 根據應用，腫瘤學領域在 2024 年佔據最大的收益佔有率，為 86.31%，佔據市場主導地位。預計在預測期內，生殖健康領域將以 12.75% 的最快複合年成長率成長。
  • 根據最終用途，醫院和實驗室部門在 2024 年佔據最大的收益佔有率，為 42.44%，佔據市場主導地位。預計專科診所部門在預測期內的複合年成長率最快，為 12.16%。
  • 根據臨床應用，治療方法選擇部分在 2024 年佔據市場最大收益佔有率，為 33.69%。預計在預測期內，早期篩檢部分將以 12.38% 的最快複合年成長率成長。
  • 儀器部分佔據市場主導地位，2024 年的收益佔有率最大，為 46.74%。預計套件和試劑產品部分在預測期內將以顯著的複合年成長率成長。
  • 根據樣本類型，血液樣本將在 2024 年佔據市場最大收益佔有率71.44%，預計在預測期內將保持主導地位。
  • 液態生物檢體市場以北美為主，2024 年的收益佔有率最大，為 51.15%。預計在預測期內，亞太地區液態生物檢體市場將以 13.02% 的最快複合年成長率成長。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場區隔和範圍
  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 癌症發生率上升
    • 人口老化加劇
    • 技術進步
    • 非侵入性治療越來越受歡迎
  • 市場限制分析
    • 重磅處方藥專利到期
  • 商業環境分析
    • SWOT分析；按因素（政治/法律、經濟/技術）
    • PESTEL分析

第4章 業務類型分析

  • 液態生物檢體市場：按類型進行的變化分析
  • 血液樣本
    • 血液樣本市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第5章 生物標記業務分析

  • 液態生物檢體市場：生物標記變異分析
  • 循環性腫瘤細胞（CTC）
    • 循環性腫瘤細胞（CTC）市場（2018-2030）
  • 循環腫瘤DNA（ctDNA）
    • 循環腫瘤DNA（ctDNA）市場（2018-2030）
  • 細胞外囊泡（EVs）
    • 細胞外囊泡（EV）市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第6章 依技術進行的業務分析

  • 液態生物檢體市場：按技術進行的變化分析
  • 多基因平行分析（NGS）
    • 下一代系統 (NGS) 市場（2018-2030）
  • 單基因分析（PCR微陣列）
    • 單基因分析（PCR微陣列）市場（2018-2030）

第7章 按應用程式進行業務分析

  • 液態生物檢體市場：按應用進行的變化分析
  • 癌症
    • 癌症市場（2018-2030）
  • 生殖醫學
    • 生殖醫學市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第8章 按最終用途分類的業務分析

  • 液態生物檢體市場：按最終用途進行的變化分析
  • 醫院和研究機構
    • 醫院和實驗室市場（2018-2030）
  • 專科診所
    • 專科診所市場（2018-2030）
  • 學術研究中心
    • 學術研究中心市場（2018-2030）
  • 其他
    • 其他液態生物檢體市場（2018-2030）

9. 按臨床用途分類的業務分析

  • 液態生物檢體市場：按臨床應用進行的變化分析
  • 治療方法方案
    • 治療方法方案市場（2018-2030）
  • 治療監測
    • 治療監測市場（2018-2030）
  • 早期癌症篩檢
    • 早期癌症篩檢市場（2018-2030）
  • 復發監測
    • 復發監測市場（2018-2030）
  • 其他
    • 其他液態生物檢體市場（2018-2030）

第10章 產品業務分析

  • 液態生物檢體市場：產品差異分析
  • 裝置
    • 設備市場（2018-2030年）
  • 耗材套件和試劑
    • 耗材試劑套件和試劑市場（2018-2030）
  • 軟體與服務
    • 軟體與服務市場（2018-2030）

第11章 區域業務分析

  • 液態生物檢體市場佔有率（按地區分類）（2024 年和 2030 年）
  • 北美洲
    • 北美液態生物檢體市場（2018-2030）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲液態生物檢體市場（2018-2030）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太液態生物檢體市場（2018-2030）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲液態生物檢體市場（2018-2030）
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 中東和非洲液態生物檢體市場（2018-2030）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第12章競爭格局

  • 參與企業概況
  • 財務表現
  • 參與企業
    • 鹽之領袖
    • 液態生物檢體市場佔有率分析（2024年）
    • 公司簡介
    • 戰略地圖
Product Code: GVR-1-68038-105-4

Liquid Biopsy Market Growth & Trends:

The global liquid biopsy market size is expected to reach USD 22.88 billion by 2030, registering a CAGR of 11.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period.

In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expected to reach 1.9 million, leading to 609,360 deaths. Companies are focusing on expanding their business operations in the clinical liquid biopsy space.

For instance, in December 2021, Helio Health and Fulgent Genetics announced the launch of the former's HelioLiver, a new liquid biopsy test for early liver cancer detection. This liquid biopsy test combines serum protein markers and cell-free DNA methylation patterns. Additionally, new research studies are aiding the development of novel liquid biopsy techniques. For instance, in July 2022, the University of Central Florida announced the development of a novel liquid biopsy technique that facilitates early detection using biomarker identification for lung and breast cancer, making the monitoring of conditions easier.

The enhanced interest of players in liquid biopsy and the increasing rate of approval of new products are further accelerating market growth. Moreover, in the past several years, studies have shown a positive outcome of liquid biopsy platforms. Governments and various regulatory bodies have also shown interest in the area by promoting multiple breakthrough devices for the rapid development of this technology. With the high adoption of the technology by various companies, along with the support of government funding and initiatives, the market is expected to grow in the coming years.

Liquid Biopsy Market Report Highlights:

  • Based on technology, the multi-gene-parallel analysis (NGS) segment led the market with the largest revenue share of 76.17% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on biomarker, the circulating tumor cells (CTC) biomarker segment led the market with the largest revenue share of 35.67% in 2024. The exosomes/microvesicles segment is anticipated to grow at the fastest CAGR of 13.82% over the forecast period.
  • Based on application, the cancer segment led the market with the largest revenue share of 86.31% in 2024.The reproductive health segment is anticipated to grow at the fastest CAGR of 12.75% over the forecast period.
  • Based on end use, the hospitals and laboratories segment led the market with the largest revenue share of 42.44% in 2024. The specialty clinics segment is anticipated to grow at the fastest CAGR of 12.16% over the forecast period.
  • Based on clinical application, the therapy selection segment led the market with the largest revenue share of 33.69% in 2024.The early screening segment is expected to grow at the fastest CAGR of 12.38% over the forecast period.
  • The instruments product segment dominated the market with the largest revenue share of 46.74% in 2024.The kits and reagents product segment is expected to grow at a significant CAGR during the forecast period.
  • Based on sample type, the blood sample segment led the market with the largest revenue share of 71.44% in 2024 and is projected to maintain its dominance over the forecast period.
  • North America dominated the liquid biopsy market with the largest revenue share of 51.15% in 2024.The liquid biopsy market in Asia Pacific is expected to grow at the fastest CAGR of 13.02% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing prevalence of cancer
    • 3.4.2. Growing geriatric population
    • 3.4.3. Technological advancements
    • 3.4.4. Increasing preference for noninvasive treatment
  • 3.5. Market Restraint Analysis
    • 3.5.1. Patent expiry of blockbuster drugs prescribed
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Liquid Biopsy Market: Type Movement Analysis
  • 4.2. Blood Sample
    • 4.2.1. Blood Sample Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Business Analysis

  • 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
  • 5.2. Circulating Tumor Cells (CTCs)
    • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2018 - 2030 (USD Million)
  • 5.3. Circulating Tumor DNA (ctDNA)
    • 5.3.1. Circulating Tumor DNA (ctDNA) Market, 2018 - 2030 (USD Million)
  • 5.4. Extracellular Vehicles (EVs)
    • 5.4.1. Extracellular Vehicles (EVs) Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Liquid Biopsy Market: Technology Movement Analysis
  • 6.2. Multi-gene-parallel Analysis (NGS)
    • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2018 - 2030 (USD Million)
  • 6.3. Single Gene Analysis (PCR Microarrays)
    • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Liquid Biopsy Market: Application Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.1. Lung Cancer
        • 7.2.1.1.1. Lung Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.2. Prostate Cancer
        • 7.2.1.2.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.3. Breast Cancer
        • 7.2.1.3.1. Breast Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.4. Colorectal Cancer
        • 7.2.1.4.1. Colorectal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.5. Leukemia
        • 7.2.1.5.1. Leukemia Market, 2018 - 2030 (USD Million)
      • 7.2.1.6. Gastrointestinal Cancer
        • 7.2.1.6.1. Gastrointestinal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.7. Others
        • 7.2.1.7.1. Others Market, 2018 - 2030 (USD Million)
  • 7.3. Reproductive Health
    • 7.3.1. Reproductive Health Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1. Liquid Biopsy Market: End-Use Movement Analysis
  • 8.2. Hospitals and Laboratories
    • 8.2.1. Hospitals and Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. Specialty Clinics
    • 8.3.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 8.4. Academic and Research Centers
    • 8.4.1. Academic and Research Centers Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 9. Clinical Application Business Analysis

  • 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
  • 9.2. Therapy Selection
    • 9.2.1. Therapy Selection Market, 2018 - 2030 (USD Million)
  • 9.3. Treatment Monitoring
    • 9.3.1. Treatment Monitoring Market, 2018 - 2030 (USD Million)
  • 9.4. Early Cancer Screening
    • 9.4.1. Early Cancer Screening Market, 2018 - 2030 (USD Million)
  • 9.5. Recurrence Monitoring
    • 9.5.1. Recurrence Monitoring Market, 2018 - 2030 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 10. Product Business Analysis

  • 10.1. Liquid Biopsy Market: Product Movement Analysis
  • 10.2. Instruments
    • 10.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 10.3. Consumables Kits, and Reagents
    • 10.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 10.4. Software and Services
    • 10.4.1. Software and Services Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Liquid Biopsy Market Share, By Region, 2024 & 2030
  • 11.2. North America
    • 11.2.1. North America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.3. Mexico
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Mexico Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.4. Argentina
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Target Disease Prevalence
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. Regulatory Framework
      • 11.5.4.5. Reimbursement Scenario
      • 11.5.4.6. Argentina Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.6. MEA
    • 11.6.1. MEA Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Liquid biopsy market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Liquid Biopsy Market Share Analysis, 2024
    • 12.3.3. Company Profiles
      • 12.3.3.1. ANGLE plc
        • 12.3.3.1.1. Company Overview
        • 12.3.3.1.2. Financial Performance
        • 12.3.3.1.3. Product Benchmarking
        • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Oncimmune Holdings PLC
        • 12.3.3.2.1. Company Overview
        • 12.3.3.2.2. Financial Performance
        • 12.3.3.2.3. Product Benchmarking
        • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Guardant Health
        • 12.3.3.3.1. Company Overview
        • 12.3.3.3.2. Financial Performance
        • 12.3.3.3.3. Product Benchmarking
        • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Myriad Genetics, Inc.
        • 12.3.3.4.1. Company Overview
        • 12.3.3.4.2. Financial Performance
        • 12.3.3.4.3. Product Benchmarking
        • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. Biocept, Inc.
        • 12.3.3.5.1. Company Overview
        • 12.3.3.5.2. Financial Performance
        • 12.3.3.5.3. Product Benchmarking
        • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. Lucence Health Inc.
        • 12.3.3.6.1. Company Overview
        • 12.3.3.6.2. Financial Performance
        • 12.3.3.6.3. Product Benchmarking
        • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Freenome Holdings, Inc.
        • 12.3.3.7.1. Company Overview
        • 12.3.3.7.2. Financial Performance
        • 12.3.3.7.3. Product Benchmarking
        • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. F. Hoffmann-La Roche Ltd.
        • 12.3.3.8.1. Company Overview
        • 12.3.3.8.2. Financial Performance
        • 12.3.3.8.3. Product Benchmarking
        • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. QIAGEN
        • 12.3.3.9.1. Company Overview
        • 12.3.3.9.2. Financial Performance
        • 12.3.3.9.3. Product Benchmarking
        • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Illumina, Inc.
        • 12.3.3.10.1. Company Overview
        • 12.3.3.10.2. Financial Performance
        • 12.3.3.10.3. Product Benchmarking
        • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Thermo Fisher Scientific, Inc.
        • 12.3.3.11.1. Company Overview
        • 12.3.3.11.2. Financial Performance
        • 12.3.3.11.3. Product Benchmarking
        • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Epigenomics AG
        • 12.3.3.12.1. Company Overview
        • 12.3.3.12.2. Financial Performance
        • 12.3.3.12.3. Product Benchmarking
        • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Disease Type/Drug Class Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • Table 1 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 3 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 4 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 8 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 11 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 12 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 13 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 North America Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 16 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 18 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 19 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 20 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 U.S. Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 23 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 25 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 26 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 27 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Canada Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 30 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 33 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 34 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Europe Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 38 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 40 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 41 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 42 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 UK Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 45 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 47 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 48 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 49 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Germany Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 52 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 54 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 55 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 France Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 59 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 61 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 62 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 63 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Italy Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 66 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 68 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 69 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 70 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Spain Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 73 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 74 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 75 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 76 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 77 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 78 Denmark Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 80 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 82 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 83 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 84 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 Sweden Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 87 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 89 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 90 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Norway Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 94 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 95 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 104 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 105 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 106 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 107 Japan Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 108 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 109 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 111 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 112 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 113 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 114 China Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 116 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 117 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 118 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 119 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 120 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 India Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 122 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 123 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 125 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 126 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 127 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 128 Australia Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 129 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 130 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 131 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 132 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 133 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 134 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 135 South Korea Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 136 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 137 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 138 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 139 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 140 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 141 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 142 Thailand Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 143 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 144 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 146 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 147 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 148 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 149 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 150 Latin America Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 151 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 152 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 153 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 154 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 155 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 156 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 157 Brazil Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 158 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 159 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 160 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 161 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 162 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 163 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 164 Mexico Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 165 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 166 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 167 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 168 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 169 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 170 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 171 Argentina Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 172 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 173 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 174 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 175 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 176 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 177 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 178 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 179 Middle East & Africa Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 180 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 181 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 182 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 183 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 184 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 185 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 186 South Africa Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 187 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 188 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 189 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 195 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 196 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 197 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 198 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 199 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 200 UAE Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 201 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 202 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 203 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 204 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 205 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 206 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 207 Kuwait Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 208 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 209 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Liquid biopsy market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Liquid biopsy market: Sample Type movement analysis
  • Fig. 16 Blood sample liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 17 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 18 Liquid biopsy market: Biomarker movement analysis
  • Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 20 Circulating Tumor DNA (ctDNA) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 21 Extracellular Vehicles (EVs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 22 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 23 Liquid biopsy market: Technology movement analysis
  • Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid biopsy market: Application movement analysis
  • Fig. 27 Cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 28 Lung cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 29 Prostate cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 30 Breast cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 31 Colorectal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 32 Leukemia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 34 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 35 Reproductive Health liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 36 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 37 Liquid biopsy market: End Use movement analysis
  • Fig. 38 Hospitals and Laboratories liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 39 Specialty clinics liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 40 Academic and research centers liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 41 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 42 Liquid biopsy market: Clinical application movement analysis
  • Fig. 43 Therapy selection liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 44 Treatment monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 45 Early cancer screening liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 46 Recurrence monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 47 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 48 Liquid biopsy market: Product movement analysis
  • Fig. 49 Instruments liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 50 Consumables kits and reagents liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 51 Software and Services liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional outlook, 2018 & 2030
  • Fig. 54 North America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 56 Canada liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 57 Europe liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 58 UK liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 59 Germany liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 60 Italy liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 62 France liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 65 Norway liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 68 China liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 69 India liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait liquid biopsy market, 2018 - 2030 (USD Million)